| 000 | 00969 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514195156.0 | ||
| 264 | 0 | _c20041018 | |
| 008 | 200410s 0 0 eng d | ||
| 022 | _a1472-4472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnston, Tom H | |
| 245 | 0 | 0 |
_aDrugs in development for Parkinson's disease. _h[electronic resource] |
| 260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cJul 2004 |
||
| 300 |
_a720-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xclassification |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 700 | 1 | _aBrotchie, Jonathan M | |
| 773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 5 _gno. 7 _gp. 720-6 |
|
| 999 |
_c14997881 _d14997881 |
||